Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

With the ascendancy of Trump, it is open season on profiteering and big pharma is no exception (“Big pharma’s plea to Trump ...

PME: Has female representation in the pharma industry changed over your career? KW: Not enough! The industry is about 50-50 ...

It takes courage for a business to pivot – especially a publicly listed one answerable to shareholders – but biotech Clever ...

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...

Unshrunk: A Story of Psychiatric Treatment Resistance, the newly published book by Laura Delano, is scaring the hell out of ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

On 'The Adam Carolla Show' podcast, healthcare industry watchdog and wellness expert Calley Means shares why he believes the left used to question pharmaceutical companies, big institutions, and war ...

American big pharma argues the PBS manipulates medicine ... of Universities Australia’s new definition. Two crucial statements are at the heart of their exposition. One is that “Zionism ...

Not ready to stop watching Common Side Effects just yet? Good news – there’s finally an update about a second season.

Formerly LBT Innovations, Adelaide-based Clever Culture Systems (ASX:CC5) is now targeting big pharma with its APAS ... aseptically clean environments meaning there’s techniques and practices ...

Emily Field, head of European pharma equity research at Barclays ... creating a wholly U.S.-based manufacturing process would mean diverting funds from researching future medicines, and amounts ...